Glycemic control in diabetic kidney disease patients

Type 1 and type 2 diabetes mellitus with long duration leads to nephropathy. Since population diabetes is increasing, mainly type 2 and so the people suffering from nephropathy. It is well-documented from clinical studies that early management of nephropathy reduces the development of end-stage renal disease. Blood sugar management in chronic kidney disease (CKD) is important because good glycemic control reduces the mortality in diabetic patients. Various options are available to treat high blood sugar, in mild to moderate renal failure cases patients can be treated with oral hypoglycemic agents while insulin is indicated in patients with moderate to severe CKD. Patients with CKD require frequent monitoring of blood sugar especially home monitoring. Blood sugar should be maintained in normal range with avoiding hypoglycemia.